Li Y, Xu W, Ren Y, Cheung H, Huang P, Kaur G
mBio. 2022; 13(5):e0184922.
PMID: 36043787
PMC: 9600731.
DOI: 10.1128/mbio.01849-22.
Lee Y, Heo W, Nam J, Jeung Y, Bae J
J Radiat Res. 2018; 59(3):245-252.
PMID: 29518205
PMC: 5967576.
DOI: 10.1093/jrr/rry005.
Du X, Tong J, Lu H, He C, Du S, Jia P
Mol Med Rep. 2017; 16(1):101-108.
PMID: 28487980
PMC: 5482122.
DOI: 10.3892/mmr.2017.6554.
Nguyen A, Hollenbach P, Richard N, Luna-Moran A, Brady H, Heise C
Lung Cancer (Auckl). 2017; 1:119-140.
PMID: 28210112
PMC: 5312472.
DOI: 10.2147/LCTT.S11726.
Kubiczkova L, Pour L, Sedlarikova L, Hajek R, Sevcikova S
J Cell Mol Med. 2014; 18(6):947-61.
PMID: 24712303
PMC: 4508135.
DOI: 10.1111/jcmm.12279.
The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.
Johnson D
Endocr Relat Cancer. 2014; 22(1):T1-17.
PMID: 24659480
PMC: 4170053.
DOI: 10.1530/ERC-14-0005.
Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
Grande L, Bretones G, Rosa-Garrido M, Garrido-Martin E, Hernandez T, Fraile S
J Biol Chem. 2012; 287(32):26495-505.
PMID: 22718761
PMC: 3410991.
DOI: 10.1074/jbc.M112.376319.
An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins.
Wei J, Stebbins J, Kitada S, Dash R, Zhai D, Placzek W
Front Oncol. 2012; 1:28.
PMID: 22655238
PMC: 3356046.
DOI: 10.3389/fonc.2011.00028.
Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency.
Wei G, Margolin A, Haery L, Brown E, Cucolo L, Julian B
Cancer Cell. 2012; 21(4):547-62.
PMID: 22516262
PMC: 3685408.
DOI: 10.1016/j.ccr.2012.02.028.
Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors.
Zhou W, Hu J, Tang H, Wang D, Huang X, He C
BMC Cancer. 2011; 11:485.
PMID: 22078414
PMC: 3226681.
DOI: 10.1186/1471-2407-11-485.
Nuclear factor-κB: a key regulator in health and disease of lungs.
Batra S, Balamayooran G, Sahoo M
Arch Immunol Ther Exp (Warsz). 2011; 59(5):335-51.
PMID: 21786215
PMC: 7079756.
DOI: 10.1007/s00005-011-0136-z.
Lipid-soluble ginseng extract induces apoptosis and G0/G1 cell cycle arrest in NCI-H460 human lung cancer cells.
Kang M, Kim H, Kang J, Lee K, Lee S, Hyun D
Plant Foods Hum Nutr. 2011; 66(2):101-6.
PMID: 21611769
DOI: 10.1007/s11130-011-0232-6.
Proteasome inhibitors induce p53-independent apoptosis in human cancer cells.
Pandit B, Gartel A
Am J Pathol. 2011; 178(1):355-60.
PMID: 21224072
PMC: 3069903.
DOI: 10.1016/j.ajpath.2010.11.010.
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J, Kitada S, Stebbins J, Placzek W, Zhai D, Wu B
J Med Chem. 2010; 53(22):8000-11.
PMID: 21033669
PMC: 3059195.
DOI: 10.1021/jm100746q.
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J, Stebbins J, Kitada S, Dash R, Placzek W, Rega M
J Med Chem. 2010; 53(10):4166-76.
PMID: 20443627
PMC: 2880850.
DOI: 10.1021/jm1001265.
ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway.
Hu Z, Sun J, Zhu X, Yang D, Zeng Y
J Transl Med. 2009; 7:74.
PMID: 19698176
PMC: 2742515.
DOI: 10.1186/1479-5876-7-74.
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J, Kitada S, Rega M, Stebbins J, Zhai D, Cellitti J
J Med Chem. 2009; 52(14):4511-23.
PMID: 19555126
PMC: 2747480.
DOI: 10.1021/jm900472s.
Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids.
Yang T, Barbone D, Fennell D, Broaddus V
Am J Respir Cell Mol Biol. 2008; 41(1):14-23.
PMID: 19097992
PMC: 2701959.
DOI: 10.1165/rcmb.2008-0320OC.
Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737.
Okumura K, Huang S, Sinicrope F
Clin Cancer Res. 2008; 14(24):8132-42.
PMID: 19088028
PMC: 2948478.
DOI: 10.1158/1078-0432.CCR-08-1665.
Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.
Li C, Li R, Grandis J, Johnson D
Mol Cancer Ther. 2008; 7(6):1647-55.
PMID: 18566236
PMC: 2534142.
DOI: 10.1158/1535-7163.MCT-07-2444.